US 7375079
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins
granted A61KA61K38/00A61P
Quick answer
US patent 7375079 (Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins) held by The United States of America as represented by the Secretary of the Army expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61P, A61P31/04, A61P39/02